$SRPT going long here

NASDAQ:SRPT   Sarepta Therapeutics, Inc
oscillators are done way oversold. we had an impulse move from the March low. A pennant about to breakout. MACD and Stoch overturning. Short term price target of $110.


Do you still believe it will reach 110$? I have march calls
+2 Reply
mykohph solemnApple37885
@solemnApple37885 it’s hard to say. Feb 25th is a catalyst bc of pdufa. IMO it should be back up to at least 105 by March. Getting back to 160 range may take a few months.

I feel like it’s a solid stock to buy at these levels. If everything goes well this week, it should start it’s ascension back to ath